Episodic to Chronic Migraine Progression
What it is
Approximately 2.5% of people with episodic migraine progress to chronic migraine each year. Risk factors include attack frequency, acute medication overuse, obesity, depression, anxiety, sleep disorders, and allodynia. Early preventive intervention is associated with reduced progression risk. Chronic migraine, once established, is harder to treat and associated with substantially greater disability.
How it works
Progression involves central sensitization of the trigeminal pain system, with gradual lowering of the activation threshold for migraine attacks. Neuroplastic changes in the trigeminal nucleus caudalis, periaqueductal gray, and cortical spreading depression thresholds contribute. Acute medication overuse accelerates progression through CGRP pathway sensitization.
What patients need to know
Some people with migraine find that over time their headaches become more frequent. There are known risk factors for this progression, and effective preventive treatment early on can help prevent it.
Prior authorization
Progression risk is a strong PA justification argument. For patients with high-frequency episodic migraine (8-14 MHD), documenting progression risk factors — attack frequency trajectory, acute medication use days, comorbid risk factors — supports early initiation of preventive therapy. Frame the clinical question as prevention of progression, not just current disability.
Documenting progression risk for a preventive therapy PA?
The PA Engine helps clinicians assemble the evidence for CGRP and Botox PA submissions — including high-frequency episodic migraine with progression risk factors. Free, no account required.
Run a PA →